Meral Beksac, MD, Ankara University, Ankara, Turkey, discusses a Chronic Malignancies Working Party (CMWP) and European Society for Blood and Marrow Transplantation (EBMT) report that investigated allogeneic hematopoietic cell transplantation (HCT) outcomes in myeloma patients on renal replacement. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).